Michele Wispelwey

Michele Wispelwey, CEO and Co-founder, has meticulously shaped her path in the healthcare industry over 18 years, distinguishing herself as a forward-thinking executive with a profound impact on women's health. Holding an MBA in Healthcare Management from Northeastern University, she has adeptly aligned women's healthcare services with the evolving demands and expectations of the modern era.

Renowned for her groundbreaking work, Michele has introduced cutting-edge health testing to New York City's elite physicians, covering areas such as molecular genetics, cancer biomarkers, and PCR testing. Her extensive experience includes pivotal roles at leading Fortune 500 companies like Labcorp and Quest Diagnostics, and she has particularly excelled in enhancing smaller, specialized laboratories, notably increasing a client portfolio to $40 million in New York City. Most recently, Michele led a privately held laboratory in developing their women's health platform, successfully preparing the company for a $60 million acquisition by a publicly traded diagnostic lab.

In founding FemGevity, a telemedicine platform dedicated to advancing women's health, Michele brings her vast experience and dedication to innovating in the femtech and consumer health sectors. Her vision is centered on empowering women to actively manage their health and achieve unparalleled well-being.

Michele's collaboration with healthcare organizations, research institutions, and diagnostic companies across the nation, alongside her work with top women's health physicians in the Northeast, has focused on driving growth and crafting solutions to complex challenges. She is passionate about fostering innovation, collaboration, and enabling data-driven decision-making among women.